Tagged with

Japan Listed Biotechs 2017-2024
Pfizer Appoints Elif Aral to Lead MERA, Focusing on Innovation and Access
Global Medicine Trends 2024-2028: Key Projections and Growth Drivers
Pharma’s Patient Reach Problem: Billions Still Left Behind
Swiss Healthcare in Crisis: Could Pharmacies & Off-Patent Medicines Hold the Solution?
Jürg Utzinger – Director, Swiss Tropical and Public Health Institute (Swiss TPH)
Martine Ruggli – President, PharmaSuisse
Daniel Kilian – CEO & Carlos Hernandez – COO, OECHSLER Mexico
Valney Suzuki – VP & GM, Novo Nordisk Mexico
Pedro Casas Alatriste – Executive VP & Director General, AmCham Mexico
Yoshio Uchida – President, Daiichi Sankyo China
Hong Kong-Shenzhen Innovation and Technology Park: The Best of Both Worlds?
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here